Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSediyama, Catarina Maria Nogueira de Oliveira-
dc.contributor.authorAbranches, Monise Viana-
dc.contributor.authorMoraes, Luís Fernando de Sousa-
dc.contributor.authorFreitas, Renata Nascimento de-
dc.contributor.authorRibeiro, Andréia Queiroz-
dc.contributor.authorPaula, Sérgio Oliveira de-
dc.contributor.authorPeluzio, Maria do Carmo Gouveia-
dc.identifier.citationSEDIYAMA, C. M. N. O et al. Comparison between two markers in the identification of free plasma DNA fractions in pacients with breast cancer. International Journal of New Technology and Research, v. 2, p. 82-86, 2016. Disponível em: <>. Acesso em: 29 ago. 2017.pt_BR
dc.description.abstractCancer is one of the most cause of death in the world, with increased incidence each year. About 1.7 million women died In 2012, 1.7 million women died in the world with breast cancer. This study aimed to quantify the FDNAF by two markers, the gene expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and ß-actin, and evaluate which is the best to detect women with breast cancer.50 women were recruited to dose the FDNAF, 30 with breast cancer and 20 healthy controls. DNA was extracted from plasma, and Real time PCR reaction using the GAPDH and β-actin were performed. The GAPDH was the most adequate marker to identify the patients with breast cancer, because they presented higher levels of fragments of free DNA, when compared to healthy controls.pt_BR
dc.titleComparison between two markers in the identification of free plasma DNA fractions in pacients with breast cancer.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Appears in Collections:DENCS - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_ComparisonTwoMakers.pdf269,46 kBAdobe PDFView/Open    Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.